-
Joint 9th International Diabetes Federation Western Pacific Region (IDF-WPR) Congress and 4th Scientific Meeting of the Asian Association for the Study of Diabetes (AASD), 24-27 November 2012, Kyoto, Japan Yoon KH, Chuang LM, Pfarr E, Hach T, Gong Y, Broedl UC Phase II (1245.
- Size:
43 kB
- Last Update:
29.10.2012
-
7th World Congress on the Prevention of Diabetes and its Complications (WCPD), 11-14 November 2012, Madrid, Spain Woerle HJ, Ferrannini E, Berk A, Manun’Ebo M, Pinnetti S, Broedl UC Phase II (1245.24; encore of ADA 2012) Safety and efficacy of empagliflozin as monotherapy or add-on to metformin in
- Size:
43 kB
- Last Update:
29.10.2012
-
- Size:
16 kB
- Last Update:
29.10.2012
-
- Size:
20 kB
- Last Update:
29.10.2012
-
- Size:
1 kB
- Last Update:
22.11.2012
-
- Size:
111 kB
- Last Update:
29.10.2012
-
Boehringer Ingelheim provided €15,000 in financial support for the International Diabetes Federation (IDF) step-by-step, as employees run to support World Diabetes Day (WDD)
- Size:
10 kB
- Last Update:
14.11.2012
-
- Size:
810 kB
- Last Update:
29.10.2012
-
Corporate Topics Corporate News & Information Corporate News & Information Research & Development R&D News & Information R&D News & Information Acute Ischaemic Stroke Stroke News & Information Stroke News & Information Cancer Cancer News & Information Cancer News & Information Cardiovascular
- Size:
17 kB
- Last Update:
8.11.2012
-
Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib*
- Size:
15 kB
- Last Update:
5.11.2012